idarubicin has been researched along with Metastase in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (23.53) | 18.7374 |
| 1990's | 5 (29.41) | 18.2507 |
| 2000's | 5 (29.41) | 29.6817 |
| 2010's | 3 (17.65) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bullova, P; Caisova, V; Gupta, G; Pacak, K; Pang, Y; Schovanek, J; Semenza, GL; Wang, H; Wolf, KI; Yang, C; Zhuang, Z | 1 |
| Alcalde-Ruiz, E; Catala-Mora, J; Chantada, GL; Croxatto, JO; Dabezies, AP; de Dávila, MTG; Dufort, G; Fandiño, AC; Kopp, K; López, JP; Ossandon, D; Parareda-Salles, A; Pérez, V; Ravindranath, Y; Reaman, G; Rey, G; Sampor, C; Suñol, M; Urbieta, M; Zelter, M | 1 |
| Guillen-Ponce, C; Molina-Garrido, MJ; Mora-Rufete, A | 1 |
| Bengala, C; Biadi, O; Conte, PF; Danesi, R; Del Tacca, M; Donati, S; Favre, C; Fogli, S; Guarneri, V; Innocenti, F; Mariani, M; Pazzagli, I | 1 |
| Delcambre, C; Delozier, T; Freyer, G; Genin, F; Lortholary, A; Piot, G; Pujade-Lauraine, E | 1 |
| Bernhard, J; Castiglione, M; Gusset, H; Hanselmann, S; Hering, F; Maibach, R; Morant, R; Pestalozzi, D; Schmid, HP | 1 |
| Arnoldi, E; Barni, S; Bolognesi, A; Intini, C; Tabiadon, D; Zaniboni, A | 1 |
| Barats, JC; Bardonnet, M; Bergerat, JP; Borel, C; Chapelle-Marcillac, I; Deplanque, G; Dufour, P; Kurtz, JE; Mathelin, C; Poulin, G; Prévost, G | 1 |
| Aita, P; Bearz, A; Boiocchi, M; Colussi, AM; Corona, G; Crivellari, D; Robieux, I; Sorio, R; Stocco, F; Toffoli, G | 1 |
| Douglas, R; Michael, B; Nabil, S; Thomas, F | 1 |
| Bogdanovski, M; McKenzie, IF; Pietersz, GA; Smyth, MJ | 1 |
| Bremer, K; Donhuijsen-Ant, R; Fritze, D; Klee, M; Possinger, K; Queisser, W; Rieche, K; Wagner, H; Westerhausen, M; Worst, P | 1 |
| Becchi, G; Cilenti, G; Farris, A; Guaraldi, M; Martoni, A; Pannuti, F; Piana, E; Saccani, F | 1 |
| Benfield, GF; Cullen, MH; Smith, SR; Woodroffe, CM | 1 |
| Di Lauro, L; Di Pietro, N; Ganzina, F; Lazzaro, B; Lopez, M; Papaldo, P | 1 |
| Amoroso, D; Conte, PF; Lionetto, R; Pronzato, P; Rosso, R; Sertoli, MR | 1 |
| Meyer, D; Nagel, GA; Schuff-Werner, P; Wander, HE | 1 |
6 trial(s) available for idarubicin and Metastase
| Article | Year |
|---|---|
Unexpected toxicities in elderly patients treated with oral idarubicin in metastatic breast cancer: the GINECO experience.
Topics: Administration, Oral; Age Factors; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antineoplastic Agents, Hormonal; Breast Neoplasms; Comorbidity; Drug Resistance, Neoplasm; Female; Humans; Idarubicin; Neoplasm Metastasis; Neutropenia; Sepsis | 2004 |
A phase II study of oral idarubicin as a treatment for metastatic hormone-refractory prostate carcinoma with special focus on prostate specific antigen doubling time. Swiss Group for Clinical Cancer Research, Berne, Switzerland.
Topics: Administration, Oral; Aged; Antibiotics, Antineoplastic; Drug Resistance, Neoplasm; Humans; Idarubicin; Male; Middle Aged; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Prostate-Specific Antigen; Prostatic Neoplasms | 1997 |
Oral idarubicin and cyclophosphamide for metastatic breast cancer in elderly patients.
Topics: Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Cyclophosphamide; Female; Humans; Idarubicin; Lymphatic Metastasis; Neoplasm Metastasis; Neoplasm Staging; Survival Analysis; Time Factors | 1998 |
Dose-finding and pharmacologic study of chronic oral idarubicin therapy in metastatic breast cancer patients.
Topics: Administration, Oral; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Breast Neoplasms; Cyclophosphamide; Daunorubicin; Docetaxel; Dose-Response Relationship, Drug; Doxorubicin; Epirubicin; Female; Fluorouracil; Humans; Idarubicin; Maximum Tolerated Dose; Methotrexate; Middle Aged; Neoplasm Metastasis; Paclitaxel; Taxoids; Time Factors | 2000 |
Oral administration of idarubicin as first line cytostatic therapy in patients with metastasized breast cancer and favourable prognosis. A trial of the phase II study group of the Association for Medical Oncology of the German Cancer Society.
Topics: Administration, Oral; Aged; Breast Neoplasms; Combined Modality Therapy; Drug Evaluation; Female; Follow-Up Studies; Humans; Idarubicin; Middle Aged; Neoplasm Metastasis; Survival Rate | 1991 |
Comparative phase II study of idarubicin versus doxorubicin in advanced breast cancer.
Topics: Breast Neoplasms; Doxorubicin; Drug Evaluation; Female; Follow-Up Studies; Humans; Idarubicin; Menopause; Middle Aged; Neoplasm Metastasis | 1990 |
11 other study(ies) available for idarubicin and Metastase
| Article | Year |
|---|---|
Anthracyclines suppress pheochromocytoma cell characteristics, including metastasis, through inhibition of the hypoxia signaling pathway.
Topics: Adrenal Gland Neoplasms; Animals; Antineoplastic Agents; Basic Helix-Loop-Helix Transcription Factors; Cell Growth Processes; Cell Line, Tumor; Endothelin-1; Erythropoietin; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Idarubicin; Mice; Mice, Nude; Neoplasm Metastasis; Pheochromocytoma; Phosphoglycerate Kinase; Protein Binding; Signal Transduction; Xenograft Model Antitumor Assays | 2017 |
Treatment of Nonmetastatic Unilateral Retinoblastoma in Children.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Cyclophosphamide; Disease-Free Survival; Etoposide; Eye Enucleation; Female; Humans; Hydrophthalmos; Idarubicin; Infant; Male; Mesna; Neoplasm Metastasis; Neoplasm Staging; Prospective Studies; Retinal Neoplasms; Retinoblastoma; Survival Rate; Vincristine | 2018 |
Oral chemotherapy in elderly women with metastatic breast cancer.
Topics: Administration, Oral; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine; Deoxycytidine; Female; Fluorouracil; Humans; Idarubicin; Infusions, Intravenous; Neoplasm Metastasis; Vinblastine; Vinorelbine | 2014 |
High-dose consolidation chemotherapy with Idarubicin and alkylating agents following induction with gemcitabine-epirubicin-paclitaxel in metastatic breast cancer: a dose finding study.
Topics: Adult; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Daunorubicin; Deoxycytidine; Disease Progression; Disease-Free Survival; Dose-Response Relationship, Drug; Epirubicin; Female; Humans; Idarubicin; Melphalan; Middle Aged; Neoplasm Metastasis; Paclitaxel; Remission Induction; Taxoids; Thiotepa; Time Factors; Transplantation Conditioning; Treatment Outcome | 2003 |
Dose-finding study of oral idarubicin and cyclophosphamide in first-line treatment of elderly patients with metastatic breast cancer.
Topics: Administration, Oral; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Confidence Intervals; Cyclophosphamide; Dose-Response Relationship, Drug; Female; Humans; Idarubicin; Neoplasm Metastasis; Neoplasm Staging; Prognosis; Remission Induction; Survival Rate; Treatment Outcome | 2000 |
Topoisomerase II inhibitor induced leukemia in a patient with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Homosexuality, Male; Humans; Idarubicin; Leukemia, Myeloid, Acute; Lymphoma, AIDS-Related; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Neoplasm Metastasis; Neoplasms, Second Primary; Topoisomerase II Inhibitors | 2001 |
Antitumor activity of idarubicin-monoclonal antibody conjugates in a disseminated thymic lymphoma model.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Neoplasm; Antigens, Ly; Antigens, Neoplasm; Idarubicin; Immunotherapy; Immunotoxins; Kidney Neoplasms; Lung Neoplasms; Lymphoma; Mice; Neoplasm Metastasis; Survival Analysis; Thymus Neoplasms | 1991 |
Testing new drugs in untreated small cell lung cancer may prejudice the results of standard treatment: a phase II study of oral idarubicin in extensive disease.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Daunorubicin; Drug Evaluation; Humans; Idarubicin; Lung Neoplasms; Middle Aged; Neoplasm Metastasis | 1987 |
Phase II evaluation of oral idarubicin (4-demethoxydaunorubicin) in patients with disseminated malignant melanoma.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Daunorubicin; Drug Evaluation; Hematologic Diseases; Humans; Idarubicin; Melanoma; Middle Aged; Nausea; Neoplasm Metastasis; Skin Neoplasms | 1986 |
Idarubicin in advanced breast cancer: a phase II study.
Topics: Aged; Breast Neoplasms; Daunorubicin; Drug Evaluation; Female; Gastrointestinal Diseases; Hematologic Diseases; Humans; Idarubicin; Middle Aged; Neoplasm Metastasis | 1986 |
Phase-II trial of oral idarubicin (4-demethoxydaunorubicin) in advanced breast cancer.
Topics: Antibiotics, Antineoplastic; Breast Neoplasms; Daunorubicin; Drug Evaluation; Female; Humans; Idarubicin; Leukopenia; Neoplasm Metastasis | 1986 |